A new class of anticoagulant drugs on the horizon is taking fresh aim at one of cardiology’s toughest challenges: how to ...

Bayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to its bow after the FDA approved it to prevent blood clots in acutely ill medical patients.

WASHINGTON — The Food and Drug Administration said Monday that a blood thinner from Johnson & Johnson appears to reduce life-threatening blood clots in high-risk patients, although it also ...

For people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.

For people taking blood thinners after experiencing a blood clot, a new study suggests that reducing the dose after six months may lower the risk of bleeding and reduce hospital visits without ...